Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?
نویسندگان
چکیده
Transcatheter aortic valve implantation (TAVI) is evolving rapidly as a therapeutic option in patients deemed to be at high risk for surgical aortic valve replacement. Early outcome and survival of controlled feasibility trials and single- center experience with TAVI have been previously reported. Valve performance and hemodynamics seem to improve significantly after TAVI. Long-term outcome up to 3 years have been demonstrated in recent studies. Admittedly, the results are encouraging with a survival rate at 2 and 3 years ranging from 62 to 74% and from 56 to 61% respectively. The improvement in hemodynamical and clinical status sustained beyond the 3 years follows up. However, paravalvular leakage after TAVI remains an important issue in this rapidely evolving field.
منابع مشابه
Trans-catheter Bioprosthetic Heart Valve Implantation in Iran (Tehran Heart Centre Experience)
Introduction: With the development of interventional cardiology in the world, in addition to coronary and aortic diseases, the treatment of heart valve diseases through catheters has recently begun. The treatment of aortic stenosis (which was only possible with open surgery and valve replacement) was first performed in the world in 2002 by Alain Cribier in France with catheter insertion of the ...
متن کاملPercutaneous transarterial aortic valve implantation: what do we know?
Transcatheter aortic valve implantation (TAVI) is assuming a major role in the routine management of patients with aortic stenosis. Surgical aortic valve replacement is generally accepted to prolong survival, on the basis of historical comparisons and long experience. However, recently percutaneous transarterial TAVI has assumed the position as the only therapy in any aortic stenosis patient gr...
متن کاملTranscatheter Aortic Valve Implantation
During the past decades, the only effective treatment option for severe, symptomatic, aortic valve stenosis was surgical aortic valve replacement. More than 10 years ago, Alain Cribier performed the first transcatheter aortic valve implantation (TAVI). Since 2007, CE-mark certified aortic valves are available for TAVI. This new technology rapidly achieved a very high clinical acceptance as a tr...
متن کاملLong-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. Transcatheter Aortic Valve Implantation Registry.
OBJECTIVES The U.K. Transcatheter Aortic Valve Implantation Registry reported 30-day and 1-year mortality rates of 7.1% and 21.4%, respectively, for patients who underwent transcatheter aortic valve replacement (TAVR) in the United Kingdom between 2007 and 2009. The study aim was to report long-term outcomes in this same cohort of patients. BACKGROUND There are few data on outcomes beyond 3 y...
متن کاملProsthetic valve endocarditis after transcatheter aortic valve implantation-diagnostic and surgical considerations.
Prosthetic valve endocarditis (PVE) after transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR) is a potential life threatening complication. Better understanding of the incidence, predictors, clinical presentation, diagnostic measures, complications and management of PVE may help improve TAVI long-term outcome. We report a case of TAVI-PVE in an 80-year-old...
متن کامل